InvestorsHub Logo
Followers 0
Posts 312
Boards Moderated 0
Alias Born 04/07/2017

Re: None

Thursday, 06/01/2017 6:00:06 PM

Thursday, June 01, 2017 6:00:06 PM

Post# of 8110
7 Marijuana Penny Stocks to Watch in June.

For investors who understand the risk and have patience, marijuana penny stocks offer some of the biggest potential profits today.

For example, shares of Medical Cannabis Payment Solutions (OTCMKTS: REFG) have climbed 71.3% in the last 12 months. Shares of OrganiGram Holdings Inc. (OTCMKTS: OGRMF) have done even better, skyrocketing 105.45% over the last 12 months.

In comparison, the Dow Jones Industrial Average is only up 18.07%.

To help investors find these explosive profits, we're giving you a list of marijuana stocks to watch in June.

However, investing in marijuana penny stocks should be treated as speculative right now because cannabis is still illegal under federal law.

marijuana penny stocksAlso, penny stocks are known to have volatile price swings, and most pot stocks trade on over-the-counter markets that aren't regulated like the Nasdaq or NYSE. The stocks on our list are speculative, too – not official recommendations.

These seven companies have recently launched new products, opened stores, conducted research and development, or made important announcements that could lead to an increase in sales.

Here are the seven pot stocks on our radar right now:

Company Stock Symbol Price as of May 31
Digipath Inc. DIGP $0.19
Earth Science Tech Inc. ETST $0.90
GB Sciences Inc. GBLX $0.28
Kaya Holdings Inc. KAYS $0.17
Lexaria Bioscience Corp. LXRP $0.37
Signal Bay Inc. SGBY $0.02
Weed Inc. BUDZ $0.62

Marijuana Penny Stocks to Watch, No. 5: GB Sciences Inc.

On May 23, medical marijuana researcher GB Sciences Inc. (OTCMKTS: GBLX) announced it was filing a patent application for chronic pain and heart therapies.

GB Science's pain solutions are free of THC, the psychoactive component of cannabis, which would limit potential abuse and make it more attractive as a medical solution.

In its May 23 press release, the company also said its novel heart disease formulations would compete in the $316 billion U.S. heart therapy market.

Shares of GBLX closed at $0.28 per share on May 31 and are down 16.05% so far in 2017.


https://moneymorning.com/2017/06/01/7-marijuana-penny-stocks-to-watch-in-june/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GBLX News